¸ñÀû: Sensorineural hearing loss (SNHL) was sporadically reported as a complication of CKD, with
limited to no high-quality studies examining the potential association. This meta-analysis aims
to investigate whether CKD patients had higher risk of developing SNHL. ¹æ¹ý:This study was conducted in accordance with the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) 2020. All studies was screened using PubMed and
Scopus from 2013 to 2023. Studies using ICD-10 codes in various national health screening
cohort was specifically included. The exposure and outcome of interest was the coding of
appropriate ICD-9 or ICD-10 of CKD and SNHL, respectively. Newcastle-Ottawa Scale (NOS)
was used to measure the quality of the studies. Statistical analysis was carried to determine
incidence rate difference (IRD) and hazard ratios (HR) of SNHL in CKD group. °á°ú:This meta-analysis comprised of 4 retrospective cohort studies, including 241.596 patients with
CKD and 665.707 patients with non-CKD (n= 907.303). The quality scores of the selected
studies were acceptable, with NOS scores of 89 points. The median of studies follow-up were
10 years (range: 5-17). The incidence of SNHL in CKD group is higher than non-CKD group
(pooled IRD 0.30/1000 PY, 95% Confidence Interval CI: 0.210.39). The risk of developing SNHL
in CKD group was significantly higher (HR 1.89, 95% CI: 1.05 - 3.43, I2 = 97.0%). Subgroup
analysis revealed the heterogeneity was probably attributed to the differences between sex
among participants (Female: HR 2.36, 95% CI: 0.93 - 0.64, I2 = 96.0%) than male (HR 1.91, 95%
CI: 0.92 - 3.94, I2 = 96.0%). °á·Ð:This study revealed that the incidence of developing SNHL was higher in patients with CKD and
higher risk 2.3 times in female compared to 1.9 times in male. |